Y-mAbs Therapeutics, Inc. - Common Stock, $0.0001 par value per share (YMAB)

131 filings reported holding YMAB - Y-mAbs Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q1 2021.
Y-mAbs Therapeutics, Inc. - Common Stock, $0.0001 par value per share (YMAB) has 116 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 26,332,523 shares of 45,101,565 outstanding shares and own 58.38% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (3,020,458 shares), BlackRock Inc. (2,524,776 shares), Sofinnova Investments, Inc. (2,194,278 shares), STATE STREET CORP (1,709,421 shares), VANGUARD GROUP INC (1,598,579 shares), FMR LLC (1,548,987 shares), Artisan Partners Limited Partnership (1,317,900 shares), ALLIANCEBERNSTEIN L.P. (1,231,338 shares), Cormorant Asset Management, LP (1,230,000 shares), and First Light Asset Management, LLC (944,253 shares).
This table shows the top 116 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.